N@N

Luca Issi Maintained (BMRN) at Hold with Decreased Target to $80 on, Oct 4th, 2024

Luca Issi of RBC Capital, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Decreased Target from $85 to $80 on, Oct 4th, 2024.

Luca has made no other calls on BMRN in the last 4 months.

There are 12 other peers that have a rating on BMRN. Out of the 12 peers that are also analyzing BMRN, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• George Farmer of "Scotiabank" Maintained at Hold with Decreased Target to $78 on, Tuesday, September 17th, 2024
• Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024

These are the ratings of the 10 analyists that currently disagree with Luca

---

• Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $115 on, Tuesday, September 17th, 2024
• Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, September 17th, 2024
• Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $90 on, Tuesday, September 17th, 2024
• Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $87 on, Tuesday, September 17th, 2024
• William Pickering of "Bernstein" Maintained at Buy with Decreased Target to $90 on, Tuesday, September 17th, 2024
• Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
• Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
• Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
• Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024

Contributing Sources

---